Effects of whole grain, fish and bilberries on serum metabolic profile and lipid transfer protein activities: A randomized trial (Sysdimet)

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Lankinen, Maria ^a   Kolehmainen, Marjukka ^a,b   Jääskeläinen, Tiina ^a   Paananen, Jussi ^a   Joukamo, Laura ^a   Kangas, Antti J ^c   Soininen, Pasi ^a,c   Poutanen, Kaisa ^a,b   Mykkänen, Hannu ^a   Gylling, Helena ^a,d   Oreŝiĉ, Matej ^b   Jauhiainen, Matti ^e   Ala Korpela, Mika ^a,c,f,g   Uusitupa, Matti ^a,h   Schwab, Ursula ^a,h  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g OULU UNIVERSITY HOSPITAL   (Finland)

^h KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN; LIPID TRANSFER PROTEIN; POLYUNSATURATED FATTY ACID;

ADULT; ARTICLE; BERRY; BILBERRY; CONTROLLED STUDY; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FISH INTAKE; FOOD INTAKE; GRAIN; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLOMICS; MOLECULAR WEIGHT; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; AGED; ANIMALS; APOLIPOPROTEINS; CEREALS; CHOLESTEROL, HDL; DIET; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FISH PRODUCTS; HUMANS; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; METABOLOME; MIDDLE AGED; PARTICLE SIZE; VACCINIUM MYRTILLUS;

EID: 84896512072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090352     Document Type: Article

References (67)

1. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S (2012) Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr 142:1304-1313.
2. Musa-Veloso K, Binns MA, Kocenas A, Chung C, Rice H, et al. (2011) Impact of low v. moderate intakes of long-chain n-3 fatty acids on risk of coronary heart disease. Br J Nutr 106:1129-1141.
3. Basu A, Rhone M, Lyons TJ (2010) Berries: emerging impact on cardiovascular health. Nutr Rev 68:168-177.
4. Olsen A, Egeberg R, Halkjaer J, Christensen J, Overvad K, Tjonneland A (2011) Healthy aspects of the Nordic diet are related to lower total mortality. J Nutr 141:639-644.
5. Adamsson V, Reumark A, Fredriksson IB, Hammarstrom E, Vessby B, et al. (2011) Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET). J Intern Med 269:150-159.
6. de Mello VD, Schwab U, Kolehmainen M, Koenig W, Siloaho M, et al. (2011) A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study. Diabetologia 54:2755-2767.
7. Uusitupa M, Hermansen K, Savolainen MJ, Schwab U, Kolehmainen M, et al. (2013) Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome-a randomized study (SYSDIET). J Intern Med 274:52-66.
8. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A (2008) Adherence to Mediterranean diet and health status: meta-analysis. BMJ 337:a1344.
9. Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB (2009) Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 119:1093-1100.
10. Salas-Salvado J, Bullo M, Babio N, Martinez-Gonzalez MA, Ibarrola-Jurado N, et al. (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14-19.
11. He K, Song Y, Daviglus ML, Liu K, Van Horn L, et al. (2004) Accumulated evidence on fish consumption and coronary heart disease mortality: a metaanalysis of cohort studies. Circulation 109:2705-2711. (Pubitemid 38737914)
12. Harris WS, Kris-Etherton PM, Harris KA (2008) Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 10:503-509.
13. Harris WS (1997) N-3 Fatty Acids and Serum Lipoproteins: Human Studies. Am J Clin Nutr 65:1645S-1654S. (Pubitemid 27187958)
14. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189:19-30. (Pubitemid 44468073)
15. Kwak SM, Myung SK, Lee YJ, Seo HG, Korean Meta-analysis Study Group (2012) Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 172:686-694.
16. Karlstrom BE, Jarvi AE, Byberg L, Berglund LG, Vessby BO (2011) Fatty fish in the diet of patients with type 2 diabetes: comparison of the metabolic effects of foods rich in n-3 and n-6 fatty acids. Am J Clin Nutr 94:26-33.
17. Akinkuolie AO, Ngwa JS, Meigs JB, Djousse L (2011) Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. Clin Nutr 30:702-707.
18. Brennan L (2013) Metabolomics in nutrition research: current status and perspectives. Biochem Soc Trans 41:670-673.
19. Soininen P, Kangas AJ, Wurtz P, Tukiainen T, Tynkkynen T, et al. (2009) Highthroughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 134:1781-1785.
20. Kettunen J, Tukiainen T, Sarin AP, Ortega-Alonso A, Tikkanen E, et al. (2012) Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 44:269-276.
21. Pirillo A, Norata GD, Catapano AL (2013) High-density lipoprotein subfractions- what the clinicians need to know. Cardiology 124:116-125.
22. Arsenault BJ, Lemieux I, Despres JP, Gagnon P, Wareham NJ, et al. (2009) HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Atherosclerosis 206:276-281.
23. Villard EF, El Khoury P, Duchene E, Bonnefont-Rousselot D, Clement K, et al. (2012) Elevated CETP activity improves plasma cholesterol efflux capacity from human macrophages in women. Arterioscler Thromb Vasc Biol 32:2341-2349.
24. Villard EF, EI Khoury P, Frisdal E, Bruckert E, Clement K, et al. (2013) Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels. Arterioscler Thromb Vasc Biol 33:822-828.
25. Vikstedt R, Metso J, Hakala J, Olkkonen VM, Ehnholm C, Jauhiainen M (2007) Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles. Biochemistry 46:11979-11986. (Pubitemid 47623766)
26. Aviram M, Vaya J (2013) Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion. Curr Opin Lipidol
27. Mukamal KJ, Mackey RH, Kuller LH, Tracy RP, Kronmal RA, et al. (2007) Alcohol consumption and lipoprotein subclasses in older adults. J Clin Endocrinol Metab 92:2559-2566. (Pubitemid 47037358)
28. Sonestedt E, Wirfalt E, Wallstrom P, Gullberg B, Drake I, et al. (2012) High disaccharide intake associates with atherogenic lipoprotein profile. Br J Nutr 107:1062-1069.
29. Bogl LH, Maranghi M, Rissanen A, Kaprio J, Taskinen MR, Pietilainen KH (2011) Dietary omega-3 polyunsaturated fatty acid intake is related to a protective high-density lipoprotein subspecies profile independent of genetic effects: a monozygotic twin pair study. Atherosclerosis 219:880-886.
30. Annuzzi G, Rivellese AA, Wang H, Patti L, Vaccaro O, et al. (2012) Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study. Am J Clin Nutr 95:1315-1322.
31. Burillo E, Martin-Fuentes P, Mateo-Gallego R, Baila-Rueda L, Cenarro A, et al. (2012) Omega-3 fatty acids and HDL. How do they work in the prevention of cardiovascular disease? Curr Vasc Pharmacol 10:432-441.
32. Erkkila A, Schwab U, Lehto S, de Mello V, Kangas A, et al. (2013, Article in press.) Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: A controlled trial. Journal of Clinical lipidology.
33. Bogl LH, Pietilainen KH, Rissanen A, Kangas AJ, Soininen P, et al. (2013) Association between habitual dietary intake and lipoprotein subclass profile in healthy young adults. Nutr Metab Cardiovasc Dis 23:1071-8.
34. Lankinen M, Schwab U, Kolehmainen M, Paananen J, Poutanen K, et al. (2011) Whole Grain Products, Fish and Bilberries Alter Glucose and Lipid Metabolism in a Randomized, Controlled Trial: The Sysdimet Study. PLoS ONE 6:e22646.
35. Wang J, Stancakova A, Soininen P, Kangas AJ, Paananen J, et al. (2012) Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men. J Intern Med 272:562-572.
36. Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, et al. (2010) Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol 6:441.
37. Wurtz P, Makinen VP, Soininen P, Kangas AJ, Tukiainen T, et al. (2012) Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes 61:1372-1380.
38. Kujala UM, Makinen VP, Heinonen I, Soininen P, Kangas AJ, et al. (2013) Long-term leisure-time physical activity and serum metabolome. Circulation 127:340-348.
39. Tukiainen T, Kettunen J, Kangas AJ, Lyytikainen LP, Soininen P, et al. (2012) Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci. Hum Mol Genet 21:1444-1455.
40. Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, et al. (2011) Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 43:1131-1138.
41. Groener JE, Pelton RW, Kostner GM (1986) Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 32:283-286. (Pubitemid 17025642)
42. Jauhiainen M, Ehnholm C (2005) Determination of human plasma phospholipid transfer protein mass and activity. Methods 36:97-101. (Pubitemid 40726141)
43. Kleemola P, Freese R, Jauhiainen M, Pahlman R, Alfthan G, Mutanen M (2002) Dietary determinants of serum paraoxonase activity in healthy humans. Atherosclerosis 160:425-432. (Pubitemid 34159337)
44. R Development Core Team R: A language and environment for statistical computing. [Homepage of R Foundation for Statistical Computing,Vienna, Austria], 2010, Available: http://www.R-project.org.
45. Pinheiro J, Bates D, DebRoy S, Sarkar D & the R Core team. nlme: Linear and Nonlinear Mixed Effects Models. 2009.
46. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57:289-300.
47. Kasbi Chadli F, Nazih H, Krempf M, Nguyen P, Ouguerram K (2013) Omega 3 Fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet. PLoS One 8:e61109.
48. Deloukas P, Kanoni S, Willenborg C, Farrall M, et al. (2013) Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45:25-33.
49. Haase CL, Tybjaerg-Hansen A, Qayyum AA, Schou J, Nordestgaard BG, Frikke-Schmidt R (2012) LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals. J Clin Endocrinol Metab 97:E248-56.
50. Rye KA, Bursill CA, Lambert G, Tabet F, Barter PJ (2009) The metabolism and anti-atherogenic properties of HDL. J Lipid Res 50 Suppl:S195-200.
51. Gordon SM, Davidson WS, Urbina EM, Dolan LM, Heink A, et al. (2013) The effects of type 2 diabetes on lipoprotein composition and arterial stiffness in male youth. Diabetes 62:2958-2967.
52. Nakanishi S, Vikstedt R, Soderlund S, Lee-Rueckert M, Hiukka A, et al. (2009) Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity. J Lipid Res 50:183-192.
53. Gelissen IC, Harris M, Rye KA, Quinn C, Brown AJ, et al. (2006) ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 26:534-540.
54. Fournier N, Paul JL, Atger V, Cogny A, Soni T, et al. (1997) HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 17:2685-2691. (Pubitemid 28016009)
55. Davidson WS, Rodrigueza WV, Lund-Katz S, Johnson WJ, Rothblat GH, Phillips MC (1995) Effects of acceptor particle size on the efflux of cellular free cholesterol. J Biol Chem 270:17106-17113.
56. Matsuura F, Wang N, Chen W, Jiang XC, Tall AR (2006) HDL from CETPdeficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE-and ABCG1-dependent pathway. J Clin Invest 116:1435-1442.
57. Graham I, Cooney MT, Bradley D, Dudina A, Reiner Z (2012) Dyslipidemias in the prevention of cardiovascular disease: risks and causality. Curr Cardiol Rep 14:709-720.
58. Soderlund S, Watanabe H, Ehnholm C, Jauhiainen M, Taskinen MR (2010) Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome. Metabolism 59:1502-1509.
59. Parra ES, Urban A, Panzoldo NB, Nakamura RT, Oliveira R, de Faria EC (2011) A reduction of CETP activity, not an increase, is associated with modestly impaired postprandial lipemia and increased HDL-cholesterol in adult asymptomatic women. Lipids Health Dis 10:87-511X-10-87.
60. Barter PJ, Rye KA (2012) Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk. J Lipid Res 53:1755-1766.
61. de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA (2004) A review of CETP and its relation to atherosclerosis. J Lipid Res 45:1967-1974. (Pubitemid 40990890)
62. Abbey M, Clifton P, Kestin M, Belling B, Nestel P (1990) Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 10:85-94. (Pubitemid 20035107)
63. Homma Y, Ohshima K, Yamaguchi H, Nakamura H, Araki G, Goto Y (1991) Effects of eicosapentaenoic acid on plasma lipoprotein subfractions and activities of lecithin:cholesterol acyltransferase and lipid transfer protein. Atherosclerosis 91:145-153.
64. Bishop BM (2013) Systematic Review of CETP Inhibitors for Increasing High-Density Lipoprotein Cholesterol: Where Do These Agents Stand in the Approval Process? Am J Ther
65. Paturi M, Tapanainen H, Reinivuo H, Pietinen P (2008) The National FINDIET 2007 Survey. Publications of the National Public Health Institute B 23
66. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, et al. (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448-453.
67. Lankinen M, Schwab U, Gopalacharyulu PV, Seppanen-Laakso T, Yetukuri L, et al. (2010) Dietary carbohydrate modification alters serum metabolic profiles in individuals with the metabolic syndrome. Nutr Metab Cardiovasc Dis 20:249-257.